Issue 7/2017
Content (12 Articles)
Cancer immunotherapy: how low-level ionizing radiation can play a key role
Marek K. Janiak, Marta Wincenciak, Aneta Cheda, Ewa M. Nowosielska, Edward J. Calabrese
Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow “in situ tumor vaccination”?
Gaël Deplanque, Keyvan Shabafrouz, Michel Obeid
HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients
Margaret R. Dunne, Adriana J. Michielsen, Katie E. O’Sullivan, Mary Clare Cathcart, Ronan Feighery, Brendan Doyle, Jenny A. Watson, Naoimh J. O’Farrell, Narayanasamy Ravi, Elaine Kay, John V. Reynolds, Elizabeth J. Ryan, Jacintha O’Sullivan
A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia
Yukio Kobayashi, Toru Sakura, Shuichi Miyawaki, Kazuyuki Toga, Shinji Sogo, Yuji Heike
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer
Riki Okita, Ai Maeda, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, Masao Nakata
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy
Toshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara, Yui Hirata, Kan Kishibe, Yuki Komabayashi, Seigo Ueda, Miki Takahara, Takumi Kumai, Kei Ishibashi, Akemi Kosaka, Naoko Aoki, Kensuke Oikawa, Yuji Uno, Naoko Akiyama, Masatoshi Sado, Hidehiro Takei, Esteban Celis, Yasuaki Harabuchi, Hiroya Kobayashi
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
Wolfgang Lilleby, Gustav Gaudernack, Paal F. Brunsvig, Ljiljana Vlatkovic, Melanie Schulz, Kate Mills, Knut Håkon Hole, Else Marit Inderberg
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment
Gülçin Gezgin, Mehmet Dogrusöz, T. Huibertus van Essen, Wilhelmina G. M. Kroes, Gregorius P. M. Luyten, Pieter A. van der Velden, Vonn Walter, Robert M. Verdijk, Thorbald van Hall, Sjoerd H. van der Burg, Martine J. Jager
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
Sara M. Melief, Marten Visser, Sjoerd H. van der Burg, Els M. E. Verdegaal
Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer
Kyu Sang Lee, Yoonjin Kwak, Soyeon Ahn, Eun Shin, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Gheeyoung Choe, Woo Ho Kim, Hye Seung Lee
Coexpressed modular gene expression reveals inverse correlation between immune responsive transcription and aggressiveness in gastric tumours
Kalaivani Kalamohan, Dhanasekaran Rathinam, Ponmathi Panneerpandian, Kumaresan Ganesan